周产期心肌病变的后期怀孕:患者层面的差异和决策
Olga Corazón Irizarry1, Jennifer Lewey2, Camille McCallister3
1Department of Obstetrics & Gynecology, St. Luke's University Health Network, Bethlehem, PA, United States of America.
American heart journal plus : cardiology research and practice
|November 8, 2024
概括
只有不到20%的周周心肌病患者在随后怀孕,通常是因为害怕复发. 这些患者在诊断时年轻,但心脏结果与没有再次怀孕的患者相似.
科学领域:
- 心脏病学 心脏病学
- 产科 产科 产科 产科 产科
- 生殖健康 生殖健康
背景情况:
- 产前心肌病 (PPCM) 是怀孕期间心力衰竭的一种罕见形式.
- 在PPCM后,关于后续怀孕 (SSP) 的决定是复杂的,并受到各种因素的影响.
研究的目的:
- 评估患者层面的差异和决策过程,为妇女考虑SSP后PPCM.
- 为了比较PPCM患者的临床和人口统计特征,有和没有SSP.
主要方法:
- 使用混合方法方法,将患者数据的定量分析与定性调查数据相结合.
- 该研究包括来自宾夕法尼亚大学卫生系统的220例PPCM病例.
- 评估了人口,临床和产科结局.
主要成果:
- 33%的患者有SSP,有37个活产. SSP患者更有可能是黑人,无卵性,在诊断时更年轻,在诊断时左心室喷射率 (LVEF) 更高.
- 在LVEF恢复率或需要高级心脏支持 (LVAD,移植) 或死亡率方面没有观察到显著差异.
- 在SSP中,41%的结果是终止,18%的结果是早期妊娠损失,41%的结果是活产,恐惧复发是终止的主要动机.
结论:
- 这个队列中不到20%的PPCM患者有SSP,对复发的恐惧显著影响了这一决定.
- 选择SSP的患者年轻,在诊断时有更高的LVEF,但与没有选择SSP的患者相比,在怀孕后经历了类似的心脏结果.
- 该研究强调了了解患者特定因素和恐惧在PPCM后后期怀孕的背景下的重要性.
相关概念视频
01:19Mitral Valve Prolapse III: Nursing Management
5
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
5
01:25Pericarditis IV: Nursing Management
2
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
2
01:22Mitral Valve Prolapse II: Assessment and Management
3
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
01:22Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
01:28Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
407
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
407